Reconsidering the causality of TIA1 mutations in ALS-Reference-Cited by-同舟云学术

Reconsidering the causality of TIA1 mutations in ALS

Published:2017-12-13 Issue:1-2 Volume:19 Page:1-3
ISSN:2167-8421
Container-title:Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
language:en
Short-container-title:Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Author:

van der Spek Rick A.¹^ORCID,van Rheenen Wouter¹,Pulit Sara L.¹^ORCID,Kenna Kevin P.²,Ticozzi Nicola³⁴,Kooyman Maarten⁵,Mclaughlin Russell L.⁶,Moisse Matthieu⁷⁸⁹^ORCID,van Eijk Kristel R.¹,van Vugt Joke J. F. A.¹,Iacoangeli Alfredo¹⁰,Andersen Peter¹¹,Nazli Basak A.¹²,Blair Ian¹³,de Carvalho Mamede¹⁴¹⁵,Chio Adriano¹⁶¹⁷^ORCID,Corcia Philippe¹⁸¹⁹,Couratier Phillipe¹⁸¹⁹,Drory Vivian E.²⁰,Glass Jonathan D.²¹²²,Hardiman Orla⁶²³,Mora Jesús S.²⁴,Morrison Karen E.²⁵,Mitne-Neto Miguel²⁶,Robberecht Wim⁷⁸⁹,Shaw Pamela J.²⁷^ORCID,Panadés Monica P.²⁸,van Damme Philip⁷⁸⁹,Silani Vincenzo³⁴,Gotkine Marc²⁹,Weber Markus³⁰,van Es Michael A.¹,Landers John E.²,Al-Chalabi Ammar³¹^ORCID,van den Berg Leonard H.¹,Veldink Jan H.¹^ORCID,

Affiliation:

1. Department of Neurology, Brain Center Rudolf Magnus University Medical Center Utrecht, Utrecht, The Netherlands;

2. Department of Neurology, University of Massachusetts Medical School, Worcester, MA, USA;

3. Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy;

4. Department of Pathophysiology and Transplantation, ‘Dino Ferrari' Center-Università degli Studi di Milano, Milan, Italy;

5. SURFsara, Amsterdam, The Netherlands;

6. Population Genetics Laboratory, Smurfit Institute of Genetics, Trinity College Dublin, Dublin, Republic of Ireland;

7. Department of Neurosciences, Experimental Neurology and Leuven Research Institute for Neuroscience and Disease (LIND), KU Leuven - University of Leuven, Leuven, Belgium;

8. Laboratory of Neurobiology, VIB, Center for Brain & Disease Research, Leuven, Belgium;

9. Department of Neurology, University Hospitals Leuven, Leuven, Belgium;

10. Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK;

11. Department of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden;

12. Suna and Inan Kırac Foundatıon Neurodegeneration Research Laboratory, Bogazici University, Istanbul, Turkey;

13. Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia;

14. Institute of Physiology, Institute of Molecular Medicine, Faculty of Medicine, University of Lisbon, Lisbon, Portugal;

15. Department of Neurosciences, Hospital de Santa Maria-CHLN, Lisbon, Portugal;

16. ‘Rita Levi Montalcini' Department of Neuroscience, ALS Centre, University of Torino, Turin, Italy;

17. Department of Neuroscience, Azienda Ospedaliera Città della Salute e della Scienza, Turin, Italy;

18. Centre SLA, CHRU de Tours, Tours, France;

19. Federation des Centres SLA Tours and Limoges, LITORALS, Tours, France;

20. Department of Neurology Tel-Aviv Sourasky Medical Centre, Israel;

21. Department Neurology, Emory University School of Medicine, Atlanta, GA, USA;

22. Emory ALS Center, Emory University School of Medicine, Atlanta, GA, USA;

23. Department of Neurology, Beaumont Hospital, Dublin, Republic of Ireland;

24. ALS Unit, Hospital San Rafael, Madrid, Spain;

25. Faculty of Medicine, University of Southampton, Southampton, UK;

26. Human Genome Research Center, Bioscience Institute, University of São Paulo, SP, Brazil;

27. Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield, UK;

28. Neurology Department, Hospital Universitari de Bellvitge, Barcelona, Spain;

29. Department of Neurology, The Agnes Ginges Center for Human Neurogenetics, Hadassah-Hebrew University Medical Center, Israel;

30. Neuromuscular Diseases Unit/ALS Clinic, Kantonsspital St. Gallen, St. Gallen, Switzerland;

31. Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, King's College London, London, UK

Publisher

Informa UK Limited

Subject

Clinical Neurology,Neurology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21678421.2017.1413118

Reference9 articles.

1. TIA1 Mutations in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Promote Phase Separation and Alter Stress Granule Dynamics

2. Neuromuscular Disease Center. Available September 19, 2017 at: http://neuromuscular.wustl.edu/musdist/distal.html#welander

3. Guidelines for investigating causality of sequence variants in human disease

4. Statistics: P values are just the tip of the iceberg

5. Exome sequencing and complex disease: practical aspects of rare variant association studies

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Updates on the Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia;Molecular Neurobiology;2022-06-30

2. Multisystem Proteinopathy Due to VCP Mutations: A Review of Clinical Heterogeneity and Genetic Diagnosis;Genes;2022-05-27

3. Genetic architecture of motor neuron diseases;Journal of the Neurological Sciences;2022-03

4. The Multifunctional Faces of T-Cell Intracellular Antigen 1 in Health and Disease;International Journal of Molecular Sciences;2022-01-26

5. Clinico-genetic findings in 509 frontotemporal dementia patients;Molecular Psychiatry;2021-09-24